| vaccinatie tegen 'Severe acute respiratory syndrome'-coronavirus 2 met niet-replicerende recombinante virale vector coderend voor 'spike'-eiwit (verrichting) |
| vaccinatie tegen SARS-CoV-2 met niet-replicerende recombinante virale vector coderend voor S-eiwit |
| toedienen van vaccin tegen COVID-19 met niet-replicerende recombinante virale vector coderend voor S-eiwit
vaccinatie tegen 'Severe acute respiratory syndrome'-coronavirus 2 met niet-replicerende recombinante virale vector coderend voor 'spike'-eiwit
actieve immunisatie met recombinante niet-replicerende virale vector coderend voor 'spike'-eiwit van SARS-CoV-2
|
| Administration of SARS-CoV-2 non-replicating viral vector vaccine |
| COVID-19 non-replicating viral vector vaccination
Administration of vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein
2019-nCoV non-replicating viral vector immunization
2019 novel coronavirus non-replicating viral vector immunization
COVID-19 non-replicating viral vector immunization
SARS-CoV-2 non-replicating viral vector vaccination
Severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccination
2019 novel coronavirus non-replicating viral vector vaccination
SARS-CoV-2 non-replicating viral vector immunization
2019-nCoV non-replicating viral vector vaccination
|
